|
|||
|
Multiple Sclerosis Info
|
Wednesday, February 20
by
multiplesclerosis
on Wed 20 Feb 2008 08:33 AM CST
Two doses of rituximab (Rituxan) diminished relapsing-remitting multiple sclerosis lesions and clinical symptoms for nearly a year, researchers more »
by
multiplesclerosis
on Wed 20 Feb 2008 08:11 AM CST
A breakthrough finding on the mechanism of myelin formation could have a major impact on the treatment of diseases such as multiple sclerosis and demyelination as a result of more »
by
multiplesclerosis
on Wed 20 Feb 2008 02:00 AM CST
Since disease-modifying therapies (DMTs) have been available, considerable healthcare resources are used by MS patients. A healthcare utilization survey was carried out from more »
by
multiplesclerosis
on Wed 20 Feb 2008 01:00 AM CST
Physical therapy is a mainstay of patients of all types with physical disabilities. Studies of MS patients have shown variable results, probably due to many reasons, such as fatigue, more »
by
multiplesclerosis
on Wed 20 Feb 2008 01:00 AM CST
Studies have shown that up to 65% of MS patients have cognitive dysfunction and that cognitive dysfunction is the greatest cause for disability. However, cognitive dysfunction is not well evaluated in the EDSS score nor more »
by
multiplesclerosis
on Wed 20 Feb 2008 12:00 AM CST
Studies examining the impact of stressful life events on MS exacerbations have given conflicting results. However, a study of war stress from the Carmel Medical Center in Haifa, Israel, after the Hezbollah-Israeli war in more »
|
||